Form Type: 4

SEC EDGAR Link
Accession Number:0001104659-22-077703
Date:2022-07-01
Issuer: ENTRADA THERAPEUTICS, INC. (TRDA)
Original Submission Date:

Reporting Person:

SETHURAMAN NATARAJAN
C/O ENTRADA THERAPEUTICS, INC.
6 TIDE STREET BOSTON, MA 02210

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 12.0 2022-07-01 deemed execution date A 34,763 (a) 2032-07-01 common stock 34,763 $12.00 34,763 direct
Footnotes
IDfootnote
f1 25% of the option shares shall vest and become exercisable on july 1, 2023, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, such that the option shares will be fully vested on july 1, 2026.
WhaleWisdom Logo

Elevate your investments